[go: up one dir, main page]

HUP0000520A2 - Új vizes gyógyszerkészítmények hajtógázmentes aeroszolokhoz - Google Patents

Új vizes gyógyszerkészítmények hajtógázmentes aeroszolokhoz

Info

Publication number
HUP0000520A2
HUP0000520A2 HU0000520A HUP0000520A HUP0000520A2 HU P0000520 A2 HUP0000520 A2 HU P0000520A2 HU 0000520 A HU0000520 A HU 0000520A HU P0000520 A HUP0000520 A HU P0000520A HU P0000520 A2 HUP0000520 A2 HU P0000520A2
Authority
HU
Hungary
Prior art keywords
production
new aqueous
propellent gas
medicament preparations
aqueous medicament
Prior art date
Application number
HU0000520A
Other languages
English (en)
Inventor
Bernhard Freund
Bernd Zierenberg
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7815979&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0000520(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of HUP0000520A2 publication Critical patent/HUP0000520A2/hu
Publication of HUP0000520A3 publication Critical patent/HUP0000520A3/hu
Publication of HU227012B1 publication Critical patent/HU227012B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

A találmány tárgyát inhalálás céljára szőlgáló hajtógázmentesaerőszőlők készítéséhez alkalmazható vizes főrmájúgyógyszerkészítmények képezik. A találmány szerinti készítmények ahatóanyagőn kívül egy kőmplexképzőt és legfeljebb 70 térfőgat% etanőlttartalmaznak, és időszakős alkalmazás esetén is biztősítják azegyenletes átlagős aerőszől-cseppméretet, tővábbá az adagőlófejdűgűlásmentes működését. ŕ
HU0000520A 1996-12-20 1997-12-16 Use of aqueous medicament preparations for the production of propellent gas-free aerosols HU227012B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19653969A DE19653969A1 (de) 1996-12-20 1996-12-20 Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
PCT/EP1997/007062 WO1998027959A2 (de) 1996-12-20 1997-12-16 Neue wässerige arzneimittelzubereitungen zur erzeugung treibgasfreier aerosole

Publications (3)

Publication Number Publication Date
HUP0000520A2 true HUP0000520A2 (hu) 2000-09-28
HUP0000520A3 HUP0000520A3 (en) 2000-10-30
HU227012B1 HU227012B1 (en) 2010-04-28

Family

ID=7815979

Family Applications (2)

Application Number Title Priority Date Filing Date
HU0000520A HU227012B1 (en) 1996-12-20 1997-12-16 Use of aqueous medicament preparations for the production of propellent gas-free aerosols
HU0600044A HU228494B1 (en) 1996-12-20 1997-12-16 Use of aqueous medicaments for the production of propellent gas-free aerosols

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU0600044A HU228494B1 (en) 1996-12-20 1997-12-16 Use of aqueous medicaments for the production of propellent gas-free aerosols

Country Status (39)

Country Link
US (3) US20010008632A1 (hu)
EP (2) EP0946146B1 (hu)
JP (1) JP4659160B2 (hu)
KR (1) KR100496723B1 (hu)
CN (1) CN1097455C (hu)
AR (1) AR008721A1 (hu)
AT (1) ATE235887T1 (hu)
AU (1) AU740543B2 (hu)
BG (1) BG64433B1 (hu)
BR (1) BRPI9713596C1 (hu)
CA (1) CA2275392C (hu)
CO (1) CO4920211A1 (hu)
DE (2) DE19653969A1 (hu)
DK (1) DK0946146T3 (hu)
EE (1) EE03949B1 (hu)
EG (1) EG23981A (hu)
ES (1) ES2196388T3 (hu)
HK (1) HK1022846A1 (hu)
HR (1) HRP970694B1 (hu)
HU (2) HU227012B1 (hu)
ID (1) ID22481A (hu)
IL (1) IL130464A (hu)
MY (1) MY124547A (hu)
NO (1) NO320652B1 (hu)
NZ (1) NZ336825A (hu)
PE (1) PE32899A1 (hu)
PL (1) PL189511B1 (hu)
PT (1) PT946146E (hu)
RS (1) RS49803B (hu)
RU (1) RU2219906C2 (hu)
SA (1) SA97180756B1 (hu)
SI (1) SI0946146T1 (hu)
SK (1) SK282910B6 (hu)
TR (1) TR199901408T2 (hu)
TW (1) TW438605B (hu)
UA (1) UA64736C2 (hu)
UY (1) UY24813A1 (hu)
WO (1) WO1998027959A2 (hu)
ZA (1) ZA9711370B (hu)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615422A1 (de) 1996-04-19 1997-11-20 Boehringer Ingelheim Kg Zweikammer-Kartusche für treibgasfreie Dosieraerosole
DE19733651A1 (de) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
DE19808295A1 (de) 1998-02-27 1999-11-11 Boehringer Ingelheim Int Behälter für eine medizinische Flüssigkeit
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
SE9803770D0 (sv) * 1998-11-05 1998-11-05 Astra Ab Dry powder pharmaceutical formulation
DE19940713A1 (de) 1999-02-23 2001-03-01 Boehringer Ingelheim Int Kartusche für eine Flüssigkeit
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US20100197719A1 (en) * 1999-05-12 2010-08-05 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
US20040002548A1 (en) * 1999-05-12 2004-01-01 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
WO2002026223A2 (en) * 2000-09-29 2002-04-04 Board Of Trustees Operating Michigan State University Catecholamine pharmaceutical compositions and methods
MXPA03003750A (es) * 2000-10-31 2004-10-15 Boehringer Ingelheim Pharma Formulacion de una solucion de inhalacion con una sal de tiotropio.
EA007604B1 (ru) * 2000-10-31 2006-12-29 Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг Ингаляционная композиция в виде раствора с солью тиотропия
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20020137764A1 (en) 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
DE10111843A1 (de) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von inflammatorischen Erkrankungen
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
DE10136555A1 (de) 2001-07-27 2003-02-13 Boehringer Ingelheim Int Optimierte Verfahren zur Bestimmung der Aerosol-Partikelgrößenverteilung und Vorrichtung zur Durchführung derartiger Verfahren
CA2460140C (en) * 2001-09-18 2009-09-01 Nycomed Danmark Aps Compositions for treatment of common cold
MXPA04003928A (es) * 2001-10-26 2005-03-31 Dey L P Solucion para inhalacion de albuterol, sistema, equipo y metodo para aliviar sintomas de asma pediatrica.
JP2010184937A (ja) * 2001-10-26 2010-08-26 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、キット、吸入溶液を中に有する１容器を作成する方法、および、吸入溶液を作成する方法
AU3297402A (en) * 2001-10-26 2003-10-30 Dey, L.P. An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US7754242B2 (en) * 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
US20040019073A1 (en) * 2002-04-11 2004-01-29 Boehringer Ingelheim Pharma Gmbh Co. Kg Aerosol formulation for inhalation containing a tiotropium salt
DE10216036A1 (de) * 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
CA2483917C (en) 2002-05-02 2013-07-30 President And Fellows Of Harvard College Formulations limiting spread of pulmonary infections
US20050220720A1 (en) * 2002-05-02 2005-10-06 David Edwards Formulations limiting spread of pulmonary infections
US20040048886A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists
US20040058950A1 (en) * 2002-07-09 2004-03-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
ES2305479T3 (es) * 2002-08-14 2008-11-01 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG Formulaciones aerosol para inhalacion que contienen un agente anticolinergico.
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
GB2400554B (en) * 2003-04-16 2007-04-18 George Margetts Treatment of angiotensin II-induced cardiovascular disease
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
US20050107417A1 (en) * 2003-07-28 2005-05-19 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising a novel anticholinergic and a betamimetic
US20050042176A1 (en) * 2003-07-28 2005-02-24 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising a novel anticholinergic and a steroid
US20050025718A1 (en) * 2003-07-31 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
US20050059643A1 (en) * 2003-08-05 2005-03-17 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising a steroid and a betamimetic
DE102004001451A1 (de) * 2004-01-08 2005-08-11 Boehringer Ingelheim International Gmbh Vorrichtung zum Haltern eines fluidischen Bauteiles
US20050203088A1 (en) * 2004-01-09 2005-09-15 Boehringer Ingelheim International Gmbh Medicament combinations based on scopine- or tropene acid esters with EGFR-kinase inhibitors
US20050207983A1 (en) 2004-03-05 2005-09-22 Pulmatrix, Inc. Formulations decreasing particle exhalation
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050256115A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta-agonists
ATE460676T1 (de) 2004-05-25 2010-03-15 Enel Distribuzione Spa Verfahren und vorrichtung zur erkennung der verdrahtungsphase einer beliebigen unbekannten phasenspannung relativ zu einer referenzphasenspannung
WO2005123064A1 (en) * 2004-06-10 2005-12-29 Board Of Trustees Of Michigan State University Adrenergic complement inhaler comprising compounds such as ascorbates tocopherols or polycaboxylic acid chelators
US8627821B2 (en) * 2005-01-10 2014-01-14 Pulmatrix, Inc. Method and device for decreasing contamination
NZ593475A (en) * 2005-05-18 2012-12-21 Pulmatrix Inc Calcium salts for reducing exhalation of infectious bioaerosol particles
ES2530991T3 (es) 2005-08-15 2015-03-09 Boehringer Ingelheim Int Procedimiento para la obtención de betamiméticos
EP1948186A1 (en) * 2005-11-09 2008-07-30 Boehringer Ingelheim International Gmbh Aerosolformulation for inhalation
US20100056559A1 (en) * 2006-05-19 2010-03-04 Boehringer Ingelheim International Gmbh Propellant-free aerosol formulation for inhalation
WO2007134965A1 (de) * 2006-05-19 2007-11-29 Boehringer Ingelheim International Gmbh Aerosolformulierung enthaltend ipratropiumbromid und salbutamolsulfat
DE102006023756A1 (de) * 2006-05-20 2007-11-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ethanolhaltige Aerosolformulierung für die Inhalation
UY30542A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
PE20080425A1 (es) * 2006-08-22 2008-06-16 Boehringer Ingelheim Int Formulacion aerosol para la inhalacion de beta-agonistas
WO2009035712A1 (en) * 2007-09-13 2009-03-19 Medtronic, Inc. Medical electrical profiled lead
FR2924344B1 (fr) * 2007-12-04 2010-04-16 Pf Medicament Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4.
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
WO2010112358A2 (de) 2009-03-31 2010-10-07 Boehringer Ingelheim International Gmbh Verfahren zur beschichtung einer oberfläche eines bauteils
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
BR112012012475B1 (pt) 2009-11-25 2020-03-03 Boehringer Ingelheim International Gmbh Nebulizador
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EP2585151B1 (en) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nebulizer
CN103200938B (zh) 2010-08-30 2018-07-31 普马特里克斯营业公司 干燥粉末配方及用于治疗肺部疾病的方法
EP2448571B1 (en) 2010-08-30 2013-06-12 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
PT2621488T (pt) 2010-09-29 2019-02-12 Pulmatrix Operating Co Inc Pós secos catiónicos
US9642798B2 (en) 2010-09-29 2017-05-09 Pulmatrix, Inc. Monovalent metal cation dry powders for inhalation
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
WO2012150131A1 (en) * 2011-05-03 2012-11-08 Chiesi Farmaceutici S.P.A. Improved suspension formulation of a corticosteroid for administration by inhalation
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
US20150136130A1 (en) 2012-02-29 2015-05-21 Pulmatrix, Inc. Inhalable dry powders
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
RU2479304C1 (ru) * 2012-05-29 2013-04-20 Шолекс Девелопмент Гмбх, Стабильный раствор фенотерола гидробромида
RU2493827C1 (ru) * 2012-10-03 2013-09-27 Шолекс Девелопмент Гмбх Стабильный комбинированный раствор фенотерола гидробромида и ипратропия бромида
MX2015013845A (es) 2013-04-01 2016-05-09 Pulmatrix Inc Polvos secos de tiotropio.
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
WO2015065219A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Раствор ипратропия бромида
WO2015065223A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Стабильный раствор фенотерола гидробромида
PL3139984T3 (pl) 2014-05-07 2021-11-08 Boehringer Ingelheim International Gmbh Nebulizator
BR112016023719B1 (pt) 2014-05-07 2021-12-21 Boehringer Ingelheim International Gmbh Nebulizador para um fluido e recipiente para um nebulizador
DK3139979T3 (da) 2014-05-07 2023-10-09 Boehringer Ingelheim Int Enhed, forstøver og fremgangsmåde
US9757365B2 (en) * 2015-05-18 2017-09-12 Glenmark Specialty S.A. Tiotropium inhalation solution for nebulization
CN109925300A (zh) * 2017-12-19 2019-06-25 北京盈科瑞创新药物研究有限公司 一种福多司坦雾化吸入用溶液制剂及其制备方法
EP4188327A1 (en) 2020-07-31 2023-06-07 Chemo Research, S.L. Combination therapy for inhalation administration

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3864E (es) * 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
DE3431727A1 (de) * 1984-08-29 1986-03-13 Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen Nasenspray gegen schnupfen und grippe mit einem gehalt an zinkglukonat
JPH0645538B2 (ja) * 1987-09-30 1994-06-15 日本化薬株式会社 ニトログリセリンスプレー剤
GB8825892D0 (en) * 1988-11-04 1988-12-07 Fisons Plc Pharmaceutical composition
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
EP0754450A1 (en) * 1990-10-16 1997-01-22 Mayor Pharmaceuticals Laboratories,Inc. Vitamin-mineral treatment methods and compositions
AU6048694A (en) * 1992-12-09 1994-07-04 Paul D. Jager Stabilized medicinal aerosol solution formulations
TW431888B (en) * 1994-02-03 2001-05-01 Schering Plough Healthcare Nasal spray compositions
DE726075T1 (de) * 1995-02-08 1996-12-12 Therapicon Srl Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
CA2225601C (en) * 1995-06-27 2003-10-14 Boehringer Ingelheim Kg New stable pharmaceutical preparation for producing propellant-free aerosols
DE19536902A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19536916A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Kg Inhalative Applikation von 2-Amino-6n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol, insbesondere seines (-)-Enantiomeren, sowie deren pharmakologisch verträgliche Säureadditionssalze
EP0808627A2 (de) * 1996-05-22 1997-11-26 Hoechst Aktiengesellschaft Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
DE19620509A1 (de) * 1996-05-22 1997-11-27 Hoechst Ag Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
DE19644646A1 (de) * 1996-10-26 1998-04-30 Mann & Hummel Filter Filter, insbesondere zur Filtrierung des Schmieröls einer Brennkraftmaschine
US20030215396A1 (en) * 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
US20060239930A1 (en) * 1997-08-04 2006-10-26 Herbert Lamche Process for nebulizing aqueous compositions containing highly concentrated insulin
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US20020111363A1 (en) * 2000-10-31 2002-08-15 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20040019073A1 (en) * 2002-04-11 2004-01-29 Boehringer Ingelheim Pharma Gmbh Co. Kg Aerosol formulation for inhalation containing a tiotropium salt

Also Published As

Publication number Publication date
BG103482A (en) 2000-01-31
JP2001507343A (ja) 2001-06-05
CN1097455C (zh) 2003-01-01
HU0600044D0 (en) 2006-03-28
RS49803B (sr) 2008-06-05
AR008721A1 (es) 2000-02-09
BR9713596A (pt) 2000-04-04
US20090185983A1 (en) 2009-07-23
IL130464A (en) 2004-12-15
EP1230916A3 (de) 2003-02-05
BR9713596B1 (pt) 2013-01-08
YU28499A (sh) 2001-09-28
ID22481A (id) 1999-10-21
EG23981A (en) 2008-02-27
NZ336825A (en) 2001-09-28
US20090099225A1 (en) 2009-04-16
WO1998027959A3 (de) 1998-08-13
KR20000057683A (ko) 2000-09-25
NO993004D0 (no) 1999-06-18
SA97180756B1 (ar) 2006-04-28
TR199901408T2 (xx) 1999-08-23
CO4920211A1 (es) 2000-05-29
NO993004L (no) 1999-06-18
TW438605B (en) 2001-06-07
PL334185A1 (en) 2000-02-14
HRP970694B1 (en) 2005-06-30
ATE235887T1 (de) 2003-04-15
EE9900307A (et) 2000-02-15
EE03949B1 (et) 2003-02-17
BG64433B1 (en) 2005-02-28
CA2275392A1 (en) 1998-07-02
HK1022846A1 (en) 2000-08-25
US20010008632A1 (en) 2001-07-19
ES2196388T3 (es) 2003-12-16
HRP970694A2 (en) 1998-10-31
EP1230916A2 (de) 2002-08-14
CA2275392C (en) 2004-06-29
BR9713596B8 (pt) 2013-02-19
EP0946146B1 (de) 2003-04-02
HU227012B1 (en) 2010-04-28
SK81499A3 (en) 2000-01-18
AU5663698A (en) 1998-07-17
BRPI9713596C1 (pt) 2021-05-25
SK282910B6 (sk) 2003-01-09
PE32899A1 (es) 1999-04-23
JP4659160B2 (ja) 2011-03-30
DK0946146T3 (da) 2003-04-22
PT946146E (pt) 2003-08-29
UA64736C2 (uk) 2004-03-15
EP0946146A2 (de) 1999-10-06
SI0946146T1 (en) 2003-10-31
KR100496723B1 (ko) 2005-06-22
ZA9711370B (en) 1998-06-22
AU740543B2 (en) 2001-11-08
HUP0000520A3 (en) 2000-10-30
UY24813A1 (es) 2000-09-29
DE19653969A1 (de) 1998-06-25
WO1998027959A2 (de) 1998-07-02
CN1240347A (zh) 2000-01-05
IL130464A0 (en) 2000-06-01
PL189511B1 (pl) 2005-08-31
RU2219906C2 (ru) 2003-12-27
DE59709722D1 (de) 2003-05-08
NO320652B1 (no) 2006-01-09
HU228494B1 (en) 2013-03-28
MY124547A (en) 2006-06-30

Similar Documents

Publication Publication Date Title
HUP0000520A2 (hu) Új vizes gyógyszerkészítmények hajtógázmentes aeroszolokhoz
ATE308317T1 (de) Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung
HUP0102337A2 (hu) Eljárás gyulladásgátló, különösen fertőtlenítő hatású és/vagy sebgyógyulást elősegítő szerek felső légutakba és/vagy fülbe történő beadására szolgáló készítmények előállítására
HUP0000299A1 (hu) Késleltetett hatóanyag-leadású gyógyszerkészítmények
HUP9802828A2 (hu) Belélegezhető vivőanyag szabályozott hatóanyag-leadású gyógyszerkészítményekhez
YU49698A (sh) Smeše koje sadrže tetrahidrolipstatin
MY115688A (en) Pharmaceutical composition for administration by inhalation
CA2438097A1 (en) Cannabinoids pharmaceutical formulations
TR200101033T2 (tr) Akış direnci hafifletilmiş, aerosol halindeki aktif maddenin verilmesi
PT954314E (pt) Formas de dosagem farmaceutica para melhorar a disfuncao erectil masculina
TR200002692T2 (tr) Aerosol haline getirilen aktif maddenin verilmesi.
AU1079701A (en) Oral transmucosal drug dosage using solid solution
HUP0102468A2 (hu) Nyomás alatti dózisadagoló inhaláló berendezés és aeroszol formájú gyógyászati készítmények
ATE159425T1 (de) Arzneimittelzusammensetzung für verabreichung von nikotin durch die nase
SE9803239D0 (sv) Composition for the treatment of acute pain
HUP0201877A2 (hu) Hal zselatint tartalmazó, gyorsan diszpergálódó dózis formák
AR013614A1 (es) Nueva composicion que comprende una combinacion de esteroides, un kit que la contiene, el uso de la misma, el uso de dicho kit de formoterol y debudesonida en la fabricacion de un medicamento
NO306894B1 (no) Anvendelse av galanthamin for fremstilling av en farmasöytisk formulering for behandling av nikotinavhengighet
HUP0002490A2 (hu) Csersav-polimer kompozíciók gyógyászati anyagok szabályozott leadására, különösen a szájüregben
MY107088A (en) Plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release,process for the production of the plaster and use thereof
ES2171440T3 (es) Composicion solida mucoadhesiva, terapeutica o higienica, para administracion por aplicacion sobre la mucosa bucal o nasal.
IL150528A0 (en) Ibuprofen containing active agent preparation
TNSN01003A1 (fr) Appareil d'administration d'aerosols a comptage de dose dans des propulseurs hydrofluoroalcanes.
BG107257A (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
ATE271852T1 (de) Verbesserte inhalationspräparate